Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study

Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

Don B. Sanders, Rachel Bittner, Margaret Rosenfeld et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 514 citations · Full text

Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis

Maria T. Britto, Uma R. Kotagal, Richard Hornung et al. · CHEST Journal · 2002 · 345 citations

Pulmonary Care, Inflammatory Lung Disease, Advanced Lung Disease +7

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

Michael W. Konstan, Patrick A. Flume, Matthias Kappler et al. · Journal of Cystic Fibrosis · 2010 · 310 citations · Full text

Eager Trial, Antibiotics, Cystic Fibrosis Patients +3

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Robert Wilson, Tobias Welte, Eva Polverino et al. · European Respiratory Journal · 2012 · 200 citations · Full text

Pulmonary Care, Inflammatory Lung Disease, Advanced Lung Disease +17

Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety

David E. Geller, Michael W. Konstan, Jeffrey M. Smith et al. · Pediatric Pulmonology · 2007 · 193 citations · Full text